Primary resistance occurs in 10 to 30% of cases [4,5] and is influenced by factors such as the type of EGFR mutation [6,7], mutant allele frequency [8], co-occurring genetic alterations [9,10,11,12], and the immunosuppressive tumour microenvironment [13]. Here, EGFR is linked to neoplasm.